BIOCRYST PHARMACEUTICALS INC - Frank Steven Stock Transaction
2026-09-02SEC Filing 4 (0000882796-26-000057)
On August 31, 2026, Frank Steven, a director at BIOCRYST PHARMACEUTICALS INC, acquired 1288 shares of common stock. This acquisition was made in lieu of the quarterly cash Board Member retainer of $12,500, with shares valued at $9.70 each. Following this transaction, Mr. Steven now owns 36,747 shares of the company's stock. The transaction was reported on September 2, 2026.